| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 5, Issue 12 1373-1380, Copyright © 1994 by American Association of Cancer Research
ARTICLES |
JL Slack and P Bornstein
Department of Biochemistry, University of Washington, Seattle 98195.
Thrombospondin-1 (TSP-1) is an extracellular glycoprotein that plays a role in neoplasia, cell growth, and differentiation. We have examined the regulation of TSP-1 mRNA in cells expressing the v-src oncogene. Rat1 fibroblasts constitutively transformed by v-src expressed TSP-1 mRNA at levels that were 10- to 50-fold lower than those observed in parental, vector-transfected control cells. To analyze the kinetics of this effect, we used a line of BALB/c 3T3 fibroblasts containing a thermolabile v-src gene. Prolonged culture of these cells at the permissive temperature also resulted in down-regulation of TSP-1 mRNA. However, at early time points after temperature shift of growth-arrested cells, we observed a 3- to 15-fold increase in TSP-1 mRNA. This induction was abolished by the tyrosine kinase inhibitor, herbimycin-A, but not by the protein synthesis inhibitor, cycloheximide. The induction of TSP-1 by v-src occurred at a transcriptional level, as determined by nuclear run-on assays. Furthermore, the effect was mediated in part by a short region of the TSP-1 promoter which contains only 41 base pairs of 5' flanking DNA and 48 base pairs of the first exon. We conclude that, while overexpression of v-src results in brief transcriptional induction of TSP-1, the ultimate result of v-src transformation, at least in rodent fibroblasts, is repression of TSP-1 gene expression.
This article has been cited by other articles:
![]() |
C. Ghoneim, M. Soula-Rothhut, C. Blanchevoye, L. Martiny, F. Antonicelli, and B. Rothhut Activating Transcription Factor-1-mediated Hepatocyte Growth Factor-induced Down-regulation of Thrombospondin-1 Expression Leads to Thyroid Cancer Cell Invasion J. Biol. Chem., May 25, 2007; 282(21): 15490 - 15497. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, C. Wang, X. Jiao, Y. Lu, M. Fu, A. A. Quong, C. Dye, J. Yang, M. Dai, X. Ju, et al. Cyclin D1 Regulates Cellular Migration through the Inhibition of Thrombospondin 1 and ROCK Signaling. Mol. Cell. Biol., June 1, 2006; 26(11): 4240 - 4256. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. SHIN, J. KO, J.-S. CHANG, D. S. MIN, C. CHOI, S. S. BAE, M. J. KIM, D. S. HYUN, J.-H. KIM, M. Y. HAN, et al. Negative regulatory role of overexpression of PLC{gamma}1 in the expression of early growth response 1 gene in rat 3Y1 fibroblasts FASEB J, October 1, 2002; 16(12): 1504 - 1514. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Baudino, C. McKay, H. Pendeville-Samain, J. A. Nilsson, K. H. Maclean, E. L. White, A. C. Davis, J. N. Ihle, and J. L. Cleveland c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression Genes & Dev., October 1, 2002; 16(19): 2530 - 2543. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Filleur, O. V. Volpert, A. Degeorges, C. Voland, F. Reiher, P. Clezardin, N. Bouck, and F. Cabon In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects Genes & Dev., June 1, 2001; 15(11): 1373 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Laderoute, R. M. Alarcon, M. D. Brody, J. M. Calaoagan, E. Y. Chen, A. M. Knapp, Z. Yun, N. C. Denko, and A. J. Giaccia Opposing Effects of Hypoxia on Expression of the Angiogenic Inhibitor Thrombospondin 1 and the Angiogenic Inducer Vascular Endothelial Growth Factor Clin. Cancer Res., July 1, 2000; 6(7): 2941 - 2950. [Abstract] [Full Text] |
||||
![]() |
A. Janz, C. Sevignani, K. Kenyon, C. V. Ngo, and A. Thomas-Tikhonenko Activation of the Myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA Nucleic Acids Res., June 1, 2000; 28(11): 2268 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Ngo, M. Gee, N. Akhtar, D. Yu, O. Volpert, R. Auerbach, and A. Thomas-Tikhonenko An in Vivo Function for the Transforming Myc Protein: Elicitation of the Angiogenic Phenotype Cell Growth Differ., April 1, 2000; 11(4): 201 - 210. [Abstract] [Full Text] |
||||
![]() |
J. Rak, Y. Mitsuhashi, C. Sheehan, A. Tamir, A. Viloria-Petit, J. Filmus, S. J. Mansour, N. G. Ahn, and R. S. Kerbel Oncogenes and Tumor Angiogenesis: Differential Modes of Vascular Endothelial Growth Factor Up-Regulation in ras-transformed Epithelial Cells and Fibroblasts Cancer Res., January 1, 2000; 60(2): 490 - 498. [Abstract] [Full Text] |
||||
![]() |
K. Bein, J. A. Ware, and M. Simons Myb-dependent Regulation of Thrombospondin 2 Expression. ROLE OF mRNA STABILITY J. Biol. Chem., August 14, 1998; 273(33): 21423 - 21429. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Tikhonenko, D. J. Black, and M. L. Linial Viral Myc Oncoproteins in Infected Fibroblasts Down-modulate Thrombospondin-1, a Possible Tumor Suppressor Gene J. Biol. Chem., November 29, 1996; 271(48): 30741 - 30747. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |